Simpson Thacher, Davis Polk and Bär & Karrer win mandates on $43bn ChemChina-Syngenta deal

Simpson Thacher & Bartlett, Davis Polk & Wardwell, and Swiss firm Bär & Karrer have landed key advisory roles on China National Chemical Corp’s (ChemChina’s) $43bn bid for Swiss seeds and pesticides group Syngenta, in what will be the largest ever acquisition by a Chinese firm.

Continue reading “Simpson Thacher, Davis Polk and Bär & Karrer win mandates on $43bn ChemChina-Syngenta deal”

US and Irish firms act on $16.5bn Tyco-Johnson Controls merger

Simpson Thacher & Bartlett, Wachtell, Lipton, Rosen & Katz, A&L Goodbody and Arthur Cox have all landed roles advising on the $16.5bn merger of industrial company Johnson Controls and security provider Tyco – a deal that will lower the new company’s tax bill.

Continue reading “US and Irish firms act on $16.5bn Tyco-Johnson Controls merger”

Deal watch: Corporate activity in November 2015

FRESHFIELDS AND LATHAM ADVISE ON BARCLAYS SPIN OFF

Freshfields Bruckhaus Deringer and Latham & Watkins have acted on the spin-off of Barclays’ natural resources private equity arm in a management buyout. Barclays Natural Resources Investments was purchased by its managers after being placed into Barclays’ non-core asset pile following a restructuring last year. Freshfields acted for Barclays, while Latham advised management.

 

Continue reading “Deal watch: Corporate activity in November 2015”

Dealwatch: Magic Circle trio and Travers Smith advise as Carlyle sells RAC stake to new investors

Clifford Chance (CC), Linklaters and Freshfields Bruckhaus Deringer have all landed advisory roles alongside Travers Smith on a deal which will see CVC Capital Partners form a partnership with Singapore sovereign wealth fund GIC to invest in the roadside assistance provider RAC through the purchase of Carlyle’s stake in the latter.

Continue reading “Dealwatch: Magic Circle trio and Travers Smith advise as Carlyle sells RAC stake to new investors”

Dealwatch: Davis Polk and Simpson Thacher lead as AstraZeneca takes over ZS Pharma for $2.7bn

Wall Street leaders Davis Polk & Wardell and Simpson Thacher & Bartlett are lead advisers on Anglo-Swedish pharma giant AstraZeneca’s $2.7bn acquisition of California-based biopharmaceutical company ZS Pharma. Continue reading “Dealwatch: Davis Polk and Simpson Thacher lead as AstraZeneca takes over ZS Pharma for $2.7bn”

DealWatch Corporate activity in October

 

MAGIC CIRCLE DUO SERVE UP QUORN DEAL

Linklaters and Allen & Overy (A&O) took lead roles as the private equity owners of meat-substitute Quorn disposed of the business to a Filipino noodle maker. Linklaters advised Monde Nissin, which bought Quorn for £550m, while Quorn’s owners Exponent Private Equity and Intermediate Capital Group were advised by A&O.

 

 

Continue reading “DealWatch Corporate activity in October”

Game over: Debevoise, A&O and Fenwick & West lead on Candy Crush maker’s sale for $6bn

Debevoise & Plimpton, Allen & Overy (A&O) and Fenwick & West have scored roles advising video game maker Activision Blizzard on the acquisition of Candy Crush creator King Digital Entertainment for $5.9bn – one of the largest deals in the fast-growing interactive entertainment industry.

Continue reading “Game over: Debevoise, A&O and Fenwick & West lead on Candy Crush maker’s sale for $6bn”